Richter Gedeon traded at 13,540.00 this Friday November 13th, decreasing 50.00 or 0.37 percent since the previous trading session. Looking back, over the last four weeks, Richter Gedeon lost 7.55 percent. Over the last 12 months, its price rose by 39.23 percent. Looking ahead, we forecast Richter Gedeon to be priced at 13,113.49 by the end of this quarter and at 11,912.89 in one year, according to Trading Economics global macro models projections and analysts expectations.
Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.